Comparison of the adverse effects of common bronchodilators used in childhood wheezing
Phase 4
Completed
- Conditions
- Health Condition 1: null- Children with wheezing
- Registration Number
- CTRI/2017/11/010335
- Lead Sponsor
- Bombay Hospital Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
All children from one month to 18 years of age admitted to the pediatric ward with wheezing were included in the study.
Exclusion Criteria
Children admitted to the intensive care units, those with co-existing renal or cardiac abnormalities, known intolerance to the drugs or currently on medications known to lower serum potassium levels or cause tachycardia like oral beta 2 agonists and diuretics, were excluded from the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Heart rate was measured by examination of the pulse and by a pulse oximeter. Oxygen saturation was monitored using a portable hand held pulse oximeter with a pediatric probe. Serum potassium levels were analysed by biochemical methods and tremors as reported by the parent or confirmed on clinical examination.Timepoint: All outcomes were measured at baseline.end of 1 hour and at the end of 24 hours
- Secondary Outcome Measures
Name Time Method ILTimepoint: NA